Hidetaka Okada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hidetaka Okada has a total of 167 co-authors. Here are the top co-authors by number of shared publications:
Hideharu Kanzaki
Kansai Medical University
10 shared publicationsAkemi Nishigaki
Department of Obstetrics and Gynecology, Kansai Medical University, Hirakata, Japan
9 shared publicationsHiroaki Tsubokura
Department of Obstetrics and Gynecology, Kansai Medical University, Hirakata, Japan
9 shared publicationsHiromi Murata
Department of Obstetrics and Gynecology, Kansai Medical University, Hirakata, Osaka 573‑1191, Japan
9 shared publications- Hiromi Murata
Department of Obstetrics and Gynecology, Kansai Medical University, Osaka, Japan
9 shared publications Tomoko Tsuzuki
Department of Obstetrics and Gynecology, Kansai Medical University, Osaka, Japan
8 shared publications
Latest Publications
- Open Access
- 15 March 2026
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1)
Impact of peritoneal metastasis on overall survival in patients with advanced endometrial cancer receiving lenvatinib plus pembrolizumab
Purpose: The combination of lenvatinib plus pembrolizumab (LP) is a standard treatment for advanced or recurrent endometrial cancer. However, the optimal starting dose of lenvatinib is debated due to its toxicity profile. This study aimed to evaluate the effectiveness and safety of the LP regimen in a real-world setting and to investigate the impact of the lenvatinib starting dose on survival outcomes. Methods: We conducted a retrospective analysis of 33 patients with advanced or recurrent endometrial cancer treated with the LP regimen at Kansai Medical University Hospital between February 2022 and August 2025. We evaluated the objective response rate (ORR), progression-free survival (PFS), overall survival (OS), and safety. Prognostic factors for survival were identified using the Kaplan-Meier method and Cox proportional hazards models. Results: The median follow-up was 27.6 months. The ORR was 48.5%, with a median PFS of 6.7 months and a median OS of 21.7 months. In exploratory multivariable analysis adjusting for age ≥ 75 years and ECOG PS ≥ 1 , a lenvatinib starting dose < 20 mg (vs. 20 mg) was associated with shorter PFS (aHR 5.83; 95% CI 1.84–18.43; p = 0.003). In contrast, peritoneal metastasis (present vs. absent) was independently associated with shorter OS (aHR 7.51; 95% CI 1.87–30.25; p = 0.005). Conclusion: In this real-world cohort, LP therapy was effective and tolerable. In exploratory analyses, lenvatinib starting dose and peritoneal metastasis showed distinct associations with PFS and OS, respectively; however, non-random dose selection and baseline imbalances limit causal interpretation. These findings should be considered hypothesis-generating and warrant prospective validation, particularly for patients with peritoneal metastasis.
- 15 March 2026
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1)
Open AccessImpact of peritoneal metastasis on overall survival in patients with advanced endometrial cancer receiving lenvatinib plus pembrolizumab
Purpose: The combination of lenvatinib plus pembrolizumab (LP) is a standard treatment for advanced or recurrent endometrial cancer. However, the optimal starting dose of lenvatinib is debated due to its toxicity profile. This study aimed to evaluate the effectiveness and safety of the LP regimen in a real-world setting and to investigate the impact of the lenvatinib starting dose on survival outcomes. Methods: We conducted a retrospective analysis of 33 patients with advanced or recurrent endometrial cancer treated with the LP regimen at Kansai Medical University Hospital between February 2022 and August 2025. We evaluated the objective response rate (ORR), progression-free survival (PFS), overall survival (OS), and safety. Prognostic factors for survival were identified using the Kaplan-Meier method and Cox proportional hazards models. Results: The median follow-up was 27.6 months. The ORR was 48.5%, with a median PFS of 6.7 months and a median OS of 21.7 months. In exploratory multivariable analysis adjusting for age ≥ 75 years and ECOG PS ≥ 1 , a lenvatinib starting dose < 20 mg (vs. 20 mg) was associated with shorter PFS (aHR 5.83; 95% CI 1.84–18.43; p = 0.003). In contrast, peritoneal metastasis (present vs. absent) was independently associated with shorter OS (aHR 7.51; 95% CI 1.87–30.25; p = 0.005). Conclusion: In this real-world cohort, LP therapy was effective and tolerable. In exploratory analyses, lenvatinib starting dose and peritoneal metastasis showed distinct associations with PFS and OS, respectively; however, non-random dose selection and baseline imbalances limit causal interpretation. These findings should be considered hypothesis-generating and warrant prospective validation, particularly for patients with peritoneal metastasis.
- 30 July 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (8) , e70008
Reproductive Endocrinology Committee, Japan Society of Obstetrics and Gynecology: Annual report 2023–2024
Since 2005, the Reproductive Endocrinology Committee of the Japan Society of Obstetrics and Gynecology has conducted research and provided recommendations for reproductive medicine and endocrinology. This report summarizes the activities of eight subcommittees over 2 years, from 2023 to 2024. These subcommittees addressed various topics, including the review of medical and social indications for oocyte cryopreservation, the current status and challenges of embryo cryopreservation and disposal, the investigation of ovulatory disorders through the HyPO‐P classification and a nationwide survey of young women with suspected polycystic ovary syndrome, the revision of polycystic ovary syndrome diagnostic criteria and the development of updated treatment guidelines, the survey of adoption rates of in vitro fertilization add‐on treatments following insurance coverage, the national survey on the diagnosis and management of diffuse uterine leiomyomatosis and hereditary leiomyomatosis and renal cell carcinoma, the establishment of a clinical registry system for adenomyomectomy cases, the management of subclinical hypothyroidism in patients with infertility, and the promotion of effective utilization of assisted reproductive technology registry data in Japan. Each subcommittee provides valuable insights into the current status of reproductive medicine in Japan, identifies key challenges, and proposes recommendations to support clinical practice and guideline development. This report will serve as a foundation for advancing reproductive medicine and ensuring high‐quality patient care in Japan.
- 30 July 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (8) , e70008
Reproductive Endocrinology Committee, Japan Society of Obstetrics and Gynecology: Annual report 2023–2024
Since 2005, the Reproductive Endocrinology Committee of the Japan Society of Obstetrics and Gynecology has conducted research and provided recommendations for reproductive medicine and endocrinology. This report summarizes the activities of eight subcommittees over 2 years, from 2023 to 2024. These subcommittees addressed various topics, including the review of medical and social indications for oocyte cryopreservation, the current status and challenges of embryo cryopreservation and disposal, the investigation of ovulatory disorders through the HyPO‐P classification and a nationwide survey of young women with suspected polycystic ovary syndrome, the revision of polycystic ovary syndrome diagnostic criteria and the development of updated treatment guidelines, the survey of adoption rates of in vitro fertilization add‐on treatments following insurance coverage, the national survey on the diagnosis and management of diffuse uterine leiomyomatosis and hereditary leiomyomatosis and renal cell carcinoma, the establishment of a clinical registry system for adenomyomectomy cases, the management of subclinical hypothyroidism in patients with infertility, and the promotion of effective utilization of assisted reproductive technology registry data in Japan. Each subcommittee provides valuable insights into the current status of reproductive medicine in Japan, identifies key challenges, and proposes recommendations to support clinical practice and guideline development. This report will serve as a foundation for advancing reproductive medicine and ensuring high‐quality patient care in Japan.
- Open Access
- 1 July 2025
- Published by MDPI AG in Nutraceuticals
- Vol. 5 (3) , 16
Regulatory Mechanism of Human Endometrial Stromal Cell Decidualization by Ergothioneine
Endometrial stromal cells (EnSCs) undergo decidualization in response to progesterone. Decidualization facilitates spiral artery remodeling, immune tolerance in the endometrium, and fetal cell invasion and placentation—all essential for successful embryo implantation. Therefore, we aimed to investigate whether ergothioneine (EGT) plays a role in reproduction, particularly in decidualization and implantation. In this study, we found that solute carrier family 22 member 4 (SLC22A4), a specific transporter of EGT—a functional food ingredient with strong anti-aging properties—is upregulated in decidualized EnSCs. The effects of EGT were examined using uterine tissues from patients, primary cultured EnSCs, EnSC cell lines, and co-cultures with a fetal cell line. We observed a significant increase in SLC22A4 expression in secretory-phase human uterine tissue, decidualized EnSCs, and EnSC cell lines. We also found that EGT regulates insulin-like growth factor binding protein 1 expression, which promotes placentation. In co-cultures of EnSC and fetal cell lines, EGT upregulated ectonucleoside triphosphate diphosphohydrolase 1 and major histocompatibility complex, class I, G expression in fetal cell lines—both critical for placentation. These findings suggest that EGT is crucial to regulating decidualization and its markers, particularly insulin-like growth factor-binding protein 1, which contributes to placentation.
- 1 July 2025
- Published by MDPI AG in Nutraceuticals
- Vol. 5 (3) , 16
Open AccessRegulatory Mechanism of Human Endometrial Stromal Cell Decidualization by Ergothioneine
Endometrial stromal cells (EnSCs) undergo decidualization in response to progesterone. Decidualization facilitates spiral artery remodeling, immune tolerance in the endometrium, and fetal cell invasion and placentation—all essential for successful embryo implantation. Therefore, we aimed to investigate whether ergothioneine (EGT) plays a role in reproduction, particularly in decidualization and implantation. In this study, we found that solute carrier family 22 member 4 (SLC22A4), a specific transporter of EGT—a functional food ingredient with strong anti-aging properties—is upregulated in decidualized EnSCs. The effects of EGT were examined using uterine tissues from patients, primary cultured EnSCs, EnSC cell lines, and co-cultures with a fetal cell line. We observed a significant increase in SLC22A4 expression in secretory-phase human uterine tissue, decidualized EnSCs, and EnSC cell lines. We also found that EGT regulates insulin-like growth factor binding protein 1 expression, which promotes placentation. In co-cultures of EnSC and fetal cell lines, EGT upregulated ectonucleoside triphosphate diphosphohydrolase 1 and major histocompatibility complex, class I, G expression in fetal cell lines—both critical for placentation. These findings suggest that EGT is crucial to regulating decidualization and its markers, particularly insulin-like growth factor-binding protein 1, which contributes to placentation.
- Open Access
- 22 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
Effects of cigarette smoke extract on angiogenesis and aromatase activity in KGN cells
Cigarette smoking is associated with negative reproductive outcomes and an increased likelihood of failed in vitro fertilization. We investigated the impact of cigarette smoke on angiogenesis and aromatase activity in human granulosa cells. The human ovarian granulosa-like tumor cell line (KGN) was exposed to different cigarette smoke extract (CSE) concentrations and/or 10-μM forskolin. mRNA and protein levels and their secretion were measured using real-time polymerase chain reaction, western blotting, and enzyme-linked immunosorbent assay techniques, respectively. Additionally, KGN cells were transfected with small interfering RNA (siRNA) targeting hypoxia-inducible factor-1α (HIF-1α) for 24 h, followed by treatment with or without (control) CSE for 48 h. Data were statistically analyzed. Compared with the control group, the CSE group showed significantly increased vascular endothelial growth factor (VEGF), N-myc downstream-regulated gene 1 (NDRG1), and HIF-1α expression. Overexpression of VEGF and NDRG1 induced by CSE was inhibited by HIF-1α siRNA transfection. Furthermore, CSE exposure decreased progesterone and estradiol levels and increased testosterone levels. It also affected the expression of genes associated with steroid hormone synthesis, decreased anti-Müllerian hormone and anti-Müllerian hormone receptor II levels, and caused SMAD signaling pathway desensitization. Thus, CSE adversely affects the maturation of human granulosa cells, affecting both angiogenesis and aromatase activity.
- 22 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-13
Open AccessEffects of cigarette smoke extract on angiogenesis and aromatase activity in KGN cells
Cigarette smoking is associated with negative reproductive outcomes and an increased likelihood of failed in vitro fertilization. We investigated the impact of cigarette smoke on angiogenesis and aromatase activity in human granulosa cells. The human ovarian granulosa-like tumor cell line (KGN) was exposed to different cigarette smoke extract (CSE) concentrations and/or 10-μM forskolin. mRNA and protein levels and their secretion were measured using real-time polymerase chain reaction, western blotting, and enzyme-linked immunosorbent assay techniques, respectively. Additionally, KGN cells were transfected with small interfering RNA (siRNA) targeting hypoxia-inducible factor-1α (HIF-1α) for 24 h, followed by treatment with or without (control) CSE for 48 h. Data were statistically analyzed. Compared with the control group, the CSE group showed significantly increased vascular endothelial growth factor (VEGF), N-myc downstream-regulated gene 1 (NDRG1), and HIF-1α expression. Overexpression of VEGF and NDRG1 induced by CSE was inhibited by HIF-1α siRNA transfection. Furthermore, CSE exposure decreased progesterone and estradiol levels and increased testosterone levels. It also affected the expression of genes associated with steroid hormone synthesis, decreased anti-Müllerian hormone and anti-Müllerian hormone receptor II levels, and caused SMAD signaling pathway desensitization. Thus, CSE adversely affects the maturation of human granulosa cells, affecting both angiogenesis and aromatase activity.
- Open Access
- 31 January 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (2) , 328
HIF-1α Promotes Luteinization via NDRG1 Induction in the Human Ovary
Background/Objectives: Hypoxia-inducible factor-1α (HIF-1α) is a transcription factor that plays a crucial role in various physiological and pathological processes of the ovary. However, the timing of HIF-1α expression and its specific biological function in the follicular development of the human ovary remain unclear. Therefore, in this study, we aimed to examine whether HIF-1α and its downstream gene, N-myc downstream-regulated gene 1 (NDRG1), exhibit stage-specific expression during the follicular development process in the human ovary. Methods: We used ovarian tissues from eight women with regular menstrual cycles who were not undergoing hormonal treatment. We investigated HIF-1α and NDRG1 expression and localization using immunohistochemistry. Further, we transfected human ovarian granulosa (KGN) cells with HIF-1α small interfering RNA (siRNA) to investigate the influence of HIF-1α on NDRG1 expression and progesterone synthesis. Results: The immunohistochemical analysis of human ovarian tissues revealed that HIF-1α was localized in the cytoplasm of granulosa cells (GCs) at both the primary and secondary follicular stages. Conversely, in tertiary and later developmental stages, HIF-1α was observed exclusively in the nucleus of GCs. Furthermore, while NDRG1 was not detected in primary follicles, it was present in all GCs beyond the tertiary stage. Notably, transfection of KGN cells with HIF-1α siRNA significantly decreased NDRG1 expression, at both the mRNA and protein levels, and in progesterone synthesis. Conclusion: Our results indicate that HIF-1α and NDRG1 are integral to follicular development and the early luteinization of pre-ovulatory follicles.
- 31 January 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (2) , 328
Open AccessHIF-1α Promotes Luteinization via NDRG1 Induction in the Human Ovary
Background/Objectives: Hypoxia-inducible factor-1α (HIF-1α) is a transcription factor that plays a crucial role in various physiological and pathological processes of the ovary. However, the timing of HIF-1α expression and its specific biological function in the follicular development of the human ovary remain unclear. Therefore, in this study, we aimed to examine whether HIF-1α and its downstream gene, N-myc downstream-regulated gene 1 (NDRG1), exhibit stage-specific expression during the follicular development process in the human ovary. Methods: We used ovarian tissues from eight women with regular menstrual cycles who were not undergoing hormonal treatment. We investigated HIF-1α and NDRG1 expression and localization using immunohistochemistry. Further, we transfected human ovarian granulosa (KGN) cells with HIF-1α small interfering RNA (siRNA) to investigate the influence of HIF-1α on NDRG1 expression and progesterone synthesis. Results: The immunohistochemical analysis of human ovarian tissues revealed that HIF-1α was localized in the cytoplasm of granulosa cells (GCs) at both the primary and secondary follicular stages. Conversely, in tertiary and later developmental stages, HIF-1α was observed exclusively in the nucleus of GCs. Furthermore, while NDRG1 was not detected in primary follicles, it was present in all GCs beyond the tertiary stage. Notably, transfection of KGN cells with HIF-1α siRNA significantly decreased NDRG1 expression, at both the mRNA and protein levels, and in progesterone synthesis. Conclusion: Our results indicate that HIF-1α and NDRG1 are integral to follicular development and the early luteinization of pre-ovulatory follicles.
- 29 August 2024
- Published by Springer Nature in Reproductive Sciences
- Vol. 32 (1) , 91-102
Monogram and Heat Map on Magnetic Resonance Imaging to Evaluate the Recommendation for Myomectomy in Patients with Infertility: A Pilot Study
Uterine myomas can cause infertility. Studies are attempting to determine the indications for myomectomy. However, the multiplicity and localization of myomas complicate this issue. We aimed to develop a visualization tool to aid patients with infertility in their decision-making for myomectomy. We included 191 women with uterine myoma attending an outpatient infertility clinic, of whom 124 patients underwent myomectomy. Of these, 65 (52.4%) patients became pregnant within 17.6 months after surgery, and 54 (83.1%) of them had a live birth. A logistic regression model predicting the pregnancy rate (area under the curve, 0.82; 95% confidence interval, 0.74–0.89; validation value, 74.6%) was generated using the leave-one-out cross-validation method. This model incorporated five factors: age, maximum level of infertility intervention following myomectomy, presence of submucosal myoma, maximum diameter of the myoma, and type of myomas (multiple or single). We successfully visualized the degree of involvement of each factor in the pregnancy rate by developing a nomogram based on this model. We expanded the data from the preoperative magnetic resonance images and applied machine learning using a convolutional neural network. The classification accuracy was 71.4% for sensitivity and 77.7% for specificity. Heatmap images, generated using gradient-weighted class activation mapping to show the classification results of this model, could distinguish between myomas that required enucleation and those that did not. Although a larger sample size is needed to further validate our findings, this innovative pilot study demonstrates the potential of machine learning to refine assessment criteria and improve patient decision-making.
- 29 August 2024
- Published by Springer Nature in Reproductive Sciences
- Vol. 32 (1) , 91-102
Monogram and Heat Map on Magnetic Resonance Imaging to Evaluate the Recommendation for Myomectomy in Patients with Infertility: A Pilot Study
Uterine myomas can cause infertility. Studies are attempting to determine the indications for myomectomy. However, the multiplicity and localization of myomas complicate this issue. We aimed to develop a visualization tool to aid patients with infertility in their decision-making for myomectomy. We included 191 women with uterine myoma attending an outpatient infertility clinic, of whom 124 patients underwent myomectomy. Of these, 65 (52.4%) patients became pregnant within 17.6 months after surgery, and 54 (83.1%) of them had a live birth. A logistic regression model predicting the pregnancy rate (area under the curve, 0.82; 95% confidence interval, 0.74–0.89; validation value, 74.6%) was generated using the leave-one-out cross-validation method. This model incorporated five factors: age, maximum level of infertility intervention following myomectomy, presence of submucosal myoma, maximum diameter of the myoma, and type of myomas (multiple or single). We successfully visualized the degree of involvement of each factor in the pregnancy rate by developing a nomogram based on this model. We expanded the data from the preoperative magnetic resonance images and applied machine learning using a convolutional neural network. The classification accuracy was 71.4% for sensitivity and 77.7% for specificity. Heatmap images, generated using gradient-weighted class activation mapping to show the classification results of this model, could distinguish between myomas that required enucleation and those that did not. Although a larger sample size is needed to further validate our findings, this innovative pilot study demonstrates the potential of machine learning to refine assessment criteria and improve patient decision-making.
- Open Access
- 26 April 2024
- Published by MDPI AG in Reproductive Medicine
- Vol. 5 (2) , 43-56
IL17A Suppresses IGFBP1 in Human Endometrial Stromal Cells
Interleukin (IL) 17A has been implicated in preeclampsia, preterm labor, and miscarriage. IL17A production in non-lymphoid tissues is mainly carried out by unconventional γδ17T cells. Innate lymphoid cells (ILCs) 3, a subgroup of innate lymphocytes, can also be a source of IL17A in the endometrium and are required from implantation to early pregnancy, with their regulation ensuring that pregnancy continues. Herein, we examined the expression of γδ17T cells and ILC3 regulators IL1B, IL23A, and IL17D and IL17A receptors (IL17RA/IL17RC) in human endometrial stromal cells (EnSCs) and cell lines (KC02-44D). Accordingly, quantitative polymerase chain reaction and immunoblotting were employed. IL1B, IL23A, and IL17D were significantly upregulated in decidualized EnSCs and KC02-44D cells. A significant augmentation in IL17RA/IL17RC was also observed in decidualization. IL17A stimulation of KC02-44D cells during decidualization suppressed the decidualization marker IGFBP1. The involvement of transcription factor Forkhead box protein O1 (FOXO1) in this repression was reflected by its translocation from the nucleus into the cytoplasm. A role for IkB kinase alpha in FOXO1 phosphorylation-mediated migration was also suggested. Taken together, our findings indicate that the secretion of IL17A by γδ17T and ILC3 cells in the uterus contributes to EnSCs function and may play critical roles in regulating IGFBP1-mediated implantation and fetal growth.
- 26 April 2024
- Published by MDPI AG in Reproductive Medicine
- Vol. 5 (2) , 43-56
Open AccessIL17A Suppresses IGFBP1 in Human Endometrial Stromal Cells
Interleukin (IL) 17A has been implicated in preeclampsia, preterm labor, and miscarriage. IL17A production in non-lymphoid tissues is mainly carried out by unconventional γδ17T cells. Innate lymphoid cells (ILCs) 3, a subgroup of innate lymphocytes, can also be a source of IL17A in the endometrium and are required from implantation to early pregnancy, with their regulation ensuring that pregnancy continues. Herein, we examined the expression of γδ17T cells and ILC3 regulators IL1B, IL23A, and IL17D and IL17A receptors (IL17RA/IL17RC) in human endometrial stromal cells (EnSCs) and cell lines (KC02-44D). Accordingly, quantitative polymerase chain reaction and immunoblotting were employed. IL1B, IL23A, and IL17D were significantly upregulated in decidualized EnSCs and KC02-44D cells. A significant augmentation in IL17RA/IL17RC was also observed in decidualization. IL17A stimulation of KC02-44D cells during decidualization suppressed the decidualization marker IGFBP1. The involvement of transcription factor Forkhead box protein O1 (FOXO1) in this repression was reflected by its translocation from the nucleus into the cytoplasm. A role for IkB kinase alpha in FOXO1 phosphorylation-mediated migration was also suggested. Taken together, our findings indicate that the secretion of IL17A by γδ17T and ILC3 cells in the uterus contributes to EnSCs function and may play critical roles in regulating IGFBP1-mediated implantation and fetal growth.
- Open Access
- 1 January 2024
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 23 (1) , e12573
Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysis
Background: Follitropin δ may be an alternative to conventional follitropin α/β for controlled ovarian stimulation (COS) within assisted reproductive treatment (ART), but its efficacy and safety remain unknown. We performed a random‐effects meta‐analysis to compare the efficacy and safety of follitropin δ and follitropin α/β.Methods: We searched randomized controlled trials comparing follitropin δ and follitropin α/β using MEDLINE, Embase, CENTRAL, ClinicalTrials.gov, and WHO‐ITCRP on December 14, 2022. The primary outcomes were the live birth rate and the incidence of moderate or severe ovarian hyperstimulation syndrome (OHSS). The certainty of the evidence was assessed using the grading of recommendations assessment, development, and evaluation approach. The protocol was registered on the Open Science Framework.Results: Three studies involving 2682 participants were included in our meta‐analysis. The results indicated that follitropin δ may result in little to no difference in live birth rates (risk ratio [RR], 1.12; 95% confidence interval [CI], 0.91–1.38; low certainty) and the incidence of moderate or severe OHSS (RR, 0.78; 95% CI, 0.48–1.26; low certainty) compared with follitropin α/β.Conclusion: Follitropin δ may result in little to no difference in COS compared with follitropin α/β, especially in terms of live births and safety.
- 1 January 2024
- Published by Wiley in Reproductive Medicine and Biology
- Vol. 23 (1) , e12573
Open AccessEfficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysis
Background: Follitropin δ may be an alternative to conventional follitropin α/β for controlled ovarian stimulation (COS) within assisted reproductive treatment (ART), but its efficacy and safety remain unknown. We performed a random‐effects meta‐analysis to compare the efficacy and safety of follitropin δ and follitropin α/β.Methods: We searched randomized controlled trials comparing follitropin δ and follitropin α/β using MEDLINE, Embase, CENTRAL, ClinicalTrials.gov, and WHO‐ITCRP on December 14, 2022. The primary outcomes were the live birth rate and the incidence of moderate or severe ovarian hyperstimulation syndrome (OHSS). The certainty of the evidence was assessed using the grading of recommendations assessment, development, and evaluation approach. The protocol was registered on the Open Science Framework.Results: Three studies involving 2682 participants were included in our meta‐analysis. The results indicated that follitropin δ may result in little to no difference in live birth rates (risk ratio [RR], 1.12; 95% confidence interval [CI], 0.91–1.38; low certainty) and the incidence of moderate or severe OHSS (RR, 0.78; 95% CI, 0.48–1.26; low certainty) compared with follitropin α/β.Conclusion: Follitropin δ may result in little to no difference in COS compared with follitropin α/β, especially in terms of live births and safety.
- Open Access
- 14 January 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (1) , 210
Inflammatory Cytokine-Induced HIF-1 Activation Promotes Epithelial–Mesenchymal Transition in Endometrial Epithelial Cells
The endometrium undergoes repeated proliferation and shedding during the menstrual cycle. Significant changes to this environment include fluctuations in the partial pressure of oxygen, exposure to a high-cytokine environment associated with intrauterine infection, and inflammation. Chronic endometritis is a condition wherein mild inflammation persists in the endometrium and is one of the causes of implantation failure and miscarriage in early pregnancy. It is thought that the invasion of embryos into the endometrium requires epithelial–mesenchymal transition (EMT)-associated changes in the endometrial epithelium. However, the effects of inflammation on the endometrium remain poorly understood. In this study, we investigated the effects of the intrauterine oxygen environment, hypoxia-inducible factor (HIF), and inflammation on the differentiation and function of endometrial epithelial cells. We elucidated the ways in which inflammatory cytokines affect HIF activity and EMT in an immortalized cell line (EM-E6/E7/TERT) derived from endometrial epithelium. Pro-inflammatory cytokines caused significant accumulation of HIF-1α protein, increased HIF-1α mRNA levels, and enhanced hypoxia-induced accumulation of HIF-1α protein. The combined effect of inflammatory cytokines and hypoxia increased the expression of EMT-inducing factors and upregulated cell migration. Our findings indicate that pro-inflammatory factors, including cytokines and LPS, work synergistically with hypoxia to activate HIF-1 and promote EMT in endometrial epithelial cells.
- 14 January 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (1) , 210
Open AccessInflammatory Cytokine-Induced HIF-1 Activation Promotes Epithelial–Mesenchymal Transition in Endometrial Epithelial Cells
The endometrium undergoes repeated proliferation and shedding during the menstrual cycle. Significant changes to this environment include fluctuations in the partial pressure of oxygen, exposure to a high-cytokine environment associated with intrauterine infection, and inflammation. Chronic endometritis is a condition wherein mild inflammation persists in the endometrium and is one of the causes of implantation failure and miscarriage in early pregnancy. It is thought that the invasion of embryos into the endometrium requires epithelial–mesenchymal transition (EMT)-associated changes in the endometrial epithelium. However, the effects of inflammation on the endometrium remain poorly understood. In this study, we investigated the effects of the intrauterine oxygen environment, hypoxia-inducible factor (HIF), and inflammation on the differentiation and function of endometrial epithelial cells. We elucidated the ways in which inflammatory cytokines affect HIF activity and EMT in an immortalized cell line (EM-E6/E7/TERT) derived from endometrial epithelium. Pro-inflammatory cytokines caused significant accumulation of HIF-1α protein, increased HIF-1α mRNA levels, and enhanced hypoxia-induced accumulation of HIF-1α protein. The combined effect of inflammatory cytokines and hypoxia increased the expression of EMT-inducing factors and upregulated cell migration. Our findings indicate that pro-inflammatory factors, including cytokines and LPS, work synergistically with hypoxia to activate HIF-1 and promote EMT in endometrial epithelial cells.
- Open Access
- 1 January 2023
- Published by The Medical Society of Kansai Medical University in The Journal of Kansai Medical University
- Vol. 74, 7-12
Detection of human coronavirus RNA in surgical smoke generated by surgical devices
多くの外科医は電気メスや超音波メス等のエネルギーデバイスを使用する.これらの機器が生体組織を熱分解することで発生する煤煙はサージカルスモークと呼ばれ,この中には発癌性物質,患者由来の細菌・悪性細胞・ウイルスなどの有害物質が含まれていることが,数多くの研究で指摘されている.2019年にパンデミックになった新型コロナウイルス感染症(COVID-19)では,患者の呼吸器・糞便・血清中にウイルスRNAが存在することが示されている.そして,患者から生じたサージカルスモークによってウイルスが手術スタッフへ感染する可能性が指摘されているが,そのリスクや予防方法を評価する情報は不十分であった.そこで,筆者らはモデル実験でサージカルスモーク中のヒトコロナウイルスRNAの存在と感染力を検証し,サージカルマスクでウイルス感染リスクを低減できる可能性を評価した.本モデルでは,切開対象からサージカルスモーク中にウイルスRNAの1/106~1/105が移行した.サージカルスモーク中のウイルスは培養細胞プラークアッセイでは直接の感染性は証明できなかったが,培養上清にはウイルスRNAが自然減衰以上に保持され,特に電気メスに比べ超音波メスによるサージカルスモークは感染性がより高い可能性が示唆された.また,サージカルマスクはサージカルスモーク中のウイルスRNAの量を99.80%以上減少させることができた.この研究により,コロナウイルス感染患者のサージカルスモーク中には,感染性のあるウイルスが存在し,サージカルマスクの着用は,その感染に対する予防策となる可能性が示された.
- 1 January 2023
- Published by The Medical Society of Kansai Medical University in The Journal of Kansai Medical University
- Vol. 74, 7-12
Open AccessDetection of human coronavirus RNA in surgical smoke generated by surgical devices
多くの外科医は電気メスや超音波メス等のエネルギーデバイスを使用する.これらの機器が生体組織を熱分解することで発生する煤煙はサージカルスモークと呼ばれ,この中には発癌性物質,患者由来の細菌・悪性細胞・ウイルスなどの有害物質が含まれていることが,数多くの研究で指摘されている.2019年にパンデミックになった新型コロナウイルス感染症(COVID-19)では,患者の呼吸器・糞便・血清中にウイルスRNAが存在することが示されている.そして,患者から生じたサージカルスモークによってウイルスが手術スタッフへ感染する可能性が指摘されているが,そのリスクや予防方法を評価する情報は不十分であった.そこで,筆者らはモデル実験でサージカルスモーク中のヒトコロナウイルスRNAの存在と感染力を検証し,サージカルマスクでウイルス感染リスクを低減できる可能性を評価した.本モデルでは,切開対象からサージカルスモーク中にウイルスRNAの1/106~1/105が移行した.サージカルスモーク中のウイルスは培養細胞プラークアッセイでは直接の感染性は証明できなかったが,培養上清にはウイルスRNAが自然減衰以上に保持され,特に電気メスに比べ超音波メスによるサージカルスモークは感染性がより高い可能性が示唆された.また,サージカルマスクはサージカルスモーク中のウイルスRNAの量を99.80%以上減少させることができた.この研究により,コロナウイルス感染患者のサージカルスモーク中には,感染性のあるウイルスが存在し,サージカルマスクの着用は,その感染に対する予防策となる可能性が示された.